PTCT·69366J200·US·equity·Healthcare - Biotechnology-13D/G
PTCT (PTC THERAPEUTICS INC) is held by 161 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($882.2M), RTW INVESTMENTS, LP ($527.8M), JANUS HENDERSON GROUP PLC ($490M). Net institutional sentiment: Mixed.
See how PTCT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer